Amkor Q2 Miss and Weak Q3 Guide Validate Caution

What happened

Amkor Technology shares tumbled after the company reported second-quarter results that disappointed and issued third-quarter sales guidance well below analyst estimates. This stumble directly challenges the base-case assumption that HDFO data center CPU revenue would begin scaling meaningfully in Q3 2026, a linchpin of the prior WAIT thesis. With revenue falling short, the risk that advanced silicon and memory constraints are deferring $50–$100 million per quarter becomes more acute, threatening utilization rates and gross margin durability. The stock’s decline reflects a market reassessing the AI‑packaging growth narrative against a backdrop of heavy capex and limited backlog visibility. The next milestone, Q3 actual results, now carries even greater weight as evidence that the HDFO ramp can still materialize.

Implication

The revenue disappointment squarely hits the core assumption that HDFO CPU revenue would provide a meaningful lift in the second half of 2026, increasing the odds that customer‑side constraints persist and defer revenue. With a high fixed‑cost structure, any shortfall in volume will pressure utilization and gross margins, potentially pushing the business toward the bear case outlined in the DeepValue report. The stock’s sharp decline suggests the market is starting to price in a delay of the AI‑packaging ramp, yet the current level may still not offer adequate margin of safety given ongoing capex intensity. We would need to see stabilization in demand signals and a credible path to 14.5%–15.5% gross margins before the risk‑reward becomes attractive. A sustained break below $55 could present an entry opportunity, but aggressive buying now is premature.

Thesis delta

The Q2 revenue miss and below‑consensus Q3 sales guidance directly undercut the base case that HDFO CPU revenue would begin scaling meaningfully in Q3 2026. This increases the likelihood that customer silicon constraints defer $50–$100 million per quarter, pushing utilization and gross margin toward the bear case range. The thesis shifts from ‘WAIT for Q3 proof’ to ‘WAIT for signs of stabilization or an attractive entry price.’